Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Reducing antibiotic resistance through antibiotic stewardship in the ambulatory setting.

Keller SC, Cosgrove SE.

Lancet Infect Dis. 2019 Nov 22. pii: S1473-3099(19)30635-8. doi: 10.1016/S1473-3099(19)30635-8. [Epub ahead of print] No abstract available.

PMID:
31767422
2.

The inconvincible patient: how clinicians perceive demand for antibiotics in the outpatient setting.

Kohut MR, Keller SC, Linder JA, Tamma PD, Cosgrove SE, Speck K, Ahn R, Dullabh P, Miller MA, Szymczak JE.

Fam Pract. 2019 Nov 6. pii: cmz066. doi: 10.1093/fampra/cmz066. [Epub ahead of print]

PMID:
31690948
3.

Prevalence of hospital antibiotic use in Argentina, 2018.

Peralta N, Camou BI, Leszczuk K, Arcidiácono D, Lerena RG, Herrera P, Cornistein W, Riera F, Cosgrove SE, Fabre V.

Infect Control Hosp Epidemiol. 2019 Nov;40(11):1301-1304. doi: 10.1017/ice.2019.243. Epub 2019 Sep 16.

PMID:
31524120
4.

Assessing burden of central line-associated bloodstream infections present on hospital admission.

Leeman H, Cosgrove SE, Williams D, Keller SC.

Am J Infect Control. 2019 Sep 9. pii: S0196-6553(19)30755-2. doi: 10.1016/j.ajic.2019.08.010. [Epub ahead of print]

PMID:
31515099
5.

Roles and Role Ambiguity in Patient- and Caregiver-Performed Outpatient Parenteral Antimicrobial Therapy.

Keller SC, Cosgrove SE, Arbaje AI, Chang RH, Krosche A, Williams D, Gurses AP.

Jt Comm J Qual Patient Saf. 2019 Nov;45(11):763-771. doi: 10.1016/j.jcjq.2019.07.003. Epub 2019 Aug 22.

PMID:
31447376
6.

Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study.

Zhang J, Haines C, Watson AJM, Hart AR, Platt MJ, Pardoll DM, Cosgrove SE, Gebo KA, Sears CL.

Gut. 2019 Nov;68(11):1971-1978. doi: 10.1136/gutjnl-2019-318593. Epub 2019 Aug 19.

PMID:
31427405
7.

Infection surveillance and prevention strategies to detect and prevent postaccess breast tissue expander infections.

Sharara SL, Saunders HM, Fabre V, Cosgrove SE, Fellerman DP, Rock C, Trexler PA, Lewis LB, Bernstein MG, Manahan MA, Sacks JM, Rosson GD, Maragakis LL.

Infect Control Hosp Epidemiol. 2019 Nov;40(11):1275-1277. doi: 10.1017/ice.2019.222. Epub 2019 Aug 13.

PMID:
31407645
8.

Evaluating accuracy of sampling strategies for fluorescent gel monitoring of patient room cleaning.

Rock C, Small BA, Hsu YJ, Gurses AP, Xie A, Scheeler V, Cummings S, Trexler P, Milstone AM, Maragakis LL, Cosgrove SE; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2019 Jul;40(7):794-797. doi: 10.1017/ice.2019.102.

PMID:
31172902
9.

It's Complicated: Patient and Informal Caregiver Performance of Outpatient Parenteral Antimicrobial Therapy-Related Tasks.

Keller SC, Cosgrove SE, Arbaje AI, Chang RH, Krosche A, Williams D, Gurses AP.

Am J Med Qual. 2019 Jun 4:1062860619853345. doi: 10.1177/1062860619853345. [Epub ahead of print]

PMID:
31161769
10.

Prescriber Behavior in Clostridioides difficile Testing: A 3-Hospital Diagnostic Stewardship Intervention.

Mizusawa M, Small BA, Hsu YJ, Sharara SL, Advic E, Kauffman C, Milstone AM, Feldman L, Pahwa AK, Trivedi JB, Landrum MB, Maragakis LL, Carroll KC, Cosgrove SE, Rock C.

Clin Infect Dis. 2019 Nov 13;69(11):2019-2021. doi: 10.1093/cid/ciz295.

PMID:
31125399
11.

Reply to Hemmige and David.

Klein EY, Tseng KK, Gatalo O, Cosgrove SE.

Clin Infect Dis. 2019 Nov 13;69(11):2040-2042. doi: 10.1093/cid/ciz348. No abstract available.

12.

Perspectives on central-line-associated bloodstream infection surveillance in home infusion therapy.

Keller SC, Alexander M, Williams D, Rock C, Han J, Schweizer M, Chopra T, Deol S, Hirsch DK, Cosgrove SE, Gorski L.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):729-731. doi: 10.1017/ice.2019.90. Epub 2019 Apr 24. No abstract available.

PMID:
31014410
13.

Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Toerper MF, Levin S, Tamma PD, Rock C, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2019 May;40(5):541-550. doi: 10.1017/ice.2019.42. Epub 2019 Mar 27.

PMID:
30915928
14.

Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem Overuse.

Tamma PD, Cosgrove SE, Avdic E, Carroll KC, Simner PJ.

Open Forum Infect Dis. 2019 Feb 19;6(3):ofz064. doi: 10.1093/ofid/ofz064. eCollection 2019 Mar. No abstract available.

15.

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Fabre V, Amoah J, Cosgrove SE, Tamma PD.

Clin Infect Dis. 2019 Nov 13;69(11):2011-2014. doi: 10.1093/cid/ciz223.

PMID:
30882137
16.

Integrating bedside nurses into antibiotic stewardship: A practical approach.

Monsees EA, Tamma PD, Cosgrove SE, Miller MA, Fabre V.

Infect Control Hosp Epidemiol. 2019 May;40(5):579-584. doi: 10.1017/ice.2018.362. Epub 2019 Feb 21.

PMID:
30786944
17.

Changing antibiotic resistance patterns for Staphylococcus aureus surgical site infections.

Khamash DF, Milstone AM, Carroll KC, Gadala A, Klein E, Maragakis LL, Cosgrove SE, Fabre V.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):486-487. doi: 10.1017/ice.2019.4. Epub 2019 Feb 20.

PMID:
30782221
18.

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.

Tamma PD, Conley AT, Cosgrove SE, Harris AD, Lautenbach E, Amoah J, Avdic E, Tolomeo P, Wise J, Subudhi S, Han JH; Antibacterial Resistance Leadership Group.

JAMA Intern Med. 2019 Mar 1;179(3):316-323. doi: 10.1001/jamainternmed.2018.6226. Erratum in: JAMA Intern Med. 2019 Nov 1;179(11):1607.

PMID:
30667477
19.

The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis.

Fabre V, Nemati K, Avdic E, Cosgrove SE, Amoah J, Tamma PD.

Open Forum Infect Dis. 2018 Dec 15;6(1):ofy339. doi: 10.1093/ofid/ofy339. eCollection 2019 Jan.

20.

Rethinking How Antibiotics Are Prescribed: Incorporating the 4 Moments of Antibiotic Decision Making Into Clinical Practice.

Tamma PD, Miller MA, Cosgrove SE.

JAMA. 2019 Jan 15;321(2):139-140. doi: 10.1001/jama.2018.19509. No abstract available.

PMID:
30589917
21.

Impact of a Prescriber-driven Antibiotic Time-out on Antibiotic Use in Hospitalized Patients.

Thom KA, Tamma PD, Harris AD, Dzintars K, Morgan DJ, Li S, Pineles L, Srinivasan A, Avdic E, Cosgrove SE.

Clin Infect Dis. 2019 Apr 24;68(9):1581-1584. doi: 10.1093/cid/ciy852.

PMID:
30517592
22.

Hazards from physical attributes of the home environment among patients on outpatient parenteral antimicrobial therapy.

Keller SC, Cosgrove SE, Kohut M, Krosche A, Chang HE, Williams D, Gurses AP.

Am J Infect Control. 2019 Apr;47(4):425-430. doi: 10.1016/j.ajic.2018.09.020. Epub 2018 Nov 22.

23.

Evaluation of environmental cleaning of patient rooms: Impact of different fluorescent gel markers.

Rock C, Xie A, Andonian J, Hsu YJ, Osei P, Keller SC, Gurses AP, Trexler P, Maragakis LL, Cosgrove SE; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2019 Jan;40(1):100-102. doi: 10.1017/ice.2018.287. Epub 2018 Nov 13.

24.

Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.

Doernberg SB, Tran TTT, Tong SYC, Paul M, Yahav D, Davis JS, Leibovici L, Boucher HW, Corey GR, Cosgrove SE, Chambers HF, Fowler VG, Evans SR, Holland TL; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2019 May 2;68(10):1691-1698. doi: 10.1093/cid/ciy766.

25.

Impact of Case-Specific Education and Face-to-Face Feedback to Prescribers and Nurses in the Management of Hospitalized Patients With a Positive Clostridium difficile Test.

Fabre V, Markou T, Sick-Samuels A, Rock C, Avdic E, Shulder S, Dzintars K, Saunders H, Andonian J, Cosgrove SE.

Open Forum Infect Dis. 2018 Sep 10;5(10):ofy226. doi: 10.1093/ofid/ofy226. eCollection 2018 Oct.

26.

How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Rock C, Tamma PD, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1491-1493. doi: 10.1017/ice.2018.236. Epub 2018 Oct 1.

27.

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.

Holland TL, Raad I, Boucher HW, Anderson DJ, Cosgrove SE, Aycock PS, Baddley JW, Chaftari AM, Chow SC, Chu VH, Carugati M, Cook P, Corey GR, Crowley AL, Daly J, Gu J, Hachem R, Horton J, Jenkins TC, Levine D, Miro JM, Pericas JM, Riska P, Rubin Z, Rupp ME, Schrank J Jr, Sims M, Wray D, Zervos M, Fowler VG Jr; Staphylococcal Bacteremia Investigators.

JAMA. 2018 Sep 25;320(12):1249-1258. doi: 10.1001/jama.2018.13155.

28.

Prescribers' knowledge, attitudes and perceptions about blood culturing practices for adult hospitalized patients: a call for action.

Fabre V, Milstone AM, Keller SC, Carroll KC, Cosgrove SE.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1394-1396. doi: 10.1017/ice.2018.224. Epub 2018 Sep 18. No abstract available.

PMID:
30226121
29.

Single Academic Center Experience of Unrestricted β-d-Glucan Implementation.

Fabre V, Markou T, DeMallie K, Mehta S, Shoham S, Tamma PD, Zhang S, Cosgrove SE.

Open Forum Infect Dis. 2018 Aug 9;5(9):ofy195. doi: 10.1093/ofid/ofy195. eCollection 2018 Sep.

30.

Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy.

Keller SC, Williams D, Levering M, Cosgrove SE.

Open Forum Infect Dis. 2018 Jun 20;5(7):ofy143. doi: 10.1093/ofid/ofy143. eCollection 2018 Jul.

31.

Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?

Tamma PD, Pierce VM, Cosgrove SE, Lautenbach E, Harris A, Rayapati D, Han JH.

Open Forum Infect Dis. 2018 Jun 8;5(6):ofy139. doi: 10.1093/ofid/ofy139. eCollection 2018 Jun.

32.

A new frontier: Central line-associated bloodstream infection surveillance in home infusion therapy.

Keller SC, Williams D, Rock C, Deol S, Trexler P, Cosgrove SE.

Am J Infect Control. 2018 Dec;46(12):1419-1421. doi: 10.1016/j.ajic.2018.05.016. Epub 2018 Jun 13. No abstract available.

33.

Role of Metronidazole in Mild Clostridium difficile Infections.

Fabre V, Dzintars K, Avdic E, Cosgrove SE.

Clin Infect Dis. 2018 Nov 28;67(12):1956-1958. doi: 10.1093/cid/ciy474. No abstract available.

PMID:
29860526
34.

The Use of Clinical Decision Support in Reducing Diagnosis of and Treatment of Asymptomatic Bacteriuria.

Keller SC, Feldman L, Smith J, Pahwa A, Cosgrove SE, Chida N.

J Hosp Med. 2018 Jun 1;13(6):392-395. doi: 10.12788/jhm.2892. Epub 2017 Dec 6.

35.

National Costs Associated With Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014.

Klein EY, Jiang W, Mojica N, Tseng KK, McNeill R, Cosgrove SE, Perl TM.

Clin Infect Dis. 2019 Jan 1;68(1):22-28. doi: 10.1093/cid/ciy399.

36.

Ambulatory Antibiotic Stewardship through a Human Factors Engineering Approach: A Systematic Review.

Keller SC, Tamma PD, Cosgrove SE, Miller MA, Sateia H, Szymczak J, Gurses AP, Linder JA.

J Am Board Fam Med. 2018 May-Jun;31(3):417-430. doi: 10.3122/jabfm.2018.03.170225.

37.

Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More.

Banoub M, Curless MS, Smith JM, Jarrell AS, Cosgrove SE, Rock C, Avdic E.

Surg Infect (Larchmt). 2018 Jul;19(5):504-509. doi: 10.1089/sur.2017.296. Epub 2018 May 2.

PMID:
29717917
38.

Reply to Chou and Trautner.

Chotiprasitakul D, Han JH, Lautenbach E, Cosgrove SE, Harris AD, Tamma PD.

Clin Infect Dis. 2018 Jul 18;67(3):483. doi: 10.1093/cid/ciy118. No abstract available.

PMID:
29617738
39.

Antimicrobial stewardship and infection prevention-leveraging the synergy: A position paper update.

Manning ML, Septimus EJ, Ashley ESD, Cosgrove SE, Fakih MG, Schweon SJ, Myers FE, Moody JA.

Am J Infect Control. 2018 Apr;46(4):364-368. doi: 10.1016/j.ajic.2018.01.001. No abstract available.

PMID:
29592832
40.

Antimicrobial Stewardship and Infection Prevention-Leveraging the Synergy: A Position Paper Update.

Manning ML, Septimus EJ, Ashley ESD, Cosgrove SE, Fakih MG, Schweon SJ, Myers FE, Moody JA.

Infect Control Hosp Epidemiol. 2018 Apr;39(4):467-472. doi: 10.1017/ice.2018.33. No abstract available.

PMID:
29576043
41.

Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.

Smith TT, Tamma PD, Do TB, Dzintars KE, Zhao Y, Cosgrove SE, Avdic E.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):161-163. doi: 10.1016/j.diagmicrobio.2018.01.027. Epub 2018 Feb 3.

PMID:
29496381
42.

Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial Therapy.

Keller SC, Dzintars K, Gorski LA, Williams D, Cosgrove SE.

Pharmacotherapy. 2018 Apr;38(4):476-481. doi: 10.1002/phar.2099. Epub 2018 Mar 30.

43.

Reply to Kinlaw et al.

Keller SC, Hsu YJ, Cosgrove SE.

Clin Infect Dis. 2018 Jul 2;67(2):318-319. doi: 10.1093/cid/ciy110. No abstract available.

44.

Infectious Diseases Physicians: Leading the Way in Antimicrobial Stewardship.

Ostrowsky B, Banerjee R, Bonomo RA, Cosgrove SE, Davidson L, Doron S, Gilbert DN, Jezek A, Lynch JB 3rd, Septimus EJ, Siddiqui J, Iovine NM; Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and the Society for Healthcare Epidemiology of America.

Clin Infect Dis. 2018 Mar 19;66(7):995-1003. doi: 10.1093/cid/cix1093. No abstract available.

PMID:
29444247
45.

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.

Chotiprasitsakul D, Tamma PD, Gadala A, Cosgrove SE.

Infect Control Hosp Epidemiol. 2018 Mar;39(3):290-296. doi: 10.1017/ice.2017.308. Epub 2018 Jan 28.

PMID:
29374504
46.

Reply to Al-Hasan et al.

Chotiprasitakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Tamma PD.

Clin Infect Dis. 2018 Jun 1;66(12):1979-1981. doi: 10.1093/cid/ciy046. No abstract available.

PMID:
29365075
47.

Improving daily patient room cleaning: an observational study using a human factors and systems engineering approach.

Xie A, Rock C, Hsu YJ, Osei P, Andonian J, Scheeler V, Keller SC, Cosgrove SE, Gurses AP; Centers for Disease Control and Prevention (CDC) Prevention Epicenter Program.

IISE Trans Occup Ergon Hum Factors. 2018;6(3-4):178-191. doi: 10.1080/24725838.2018.1487348. Epub 2018 Sep 25.

48.

Residential proximity to high-density poultry operations associated with campylobacteriosis and infectious diarrhea.

Poulsen MN, Pollak J, Sills DL, Casey JA, Rasmussen SG, Nachman KE, Cosgrove SE, Stewart D, Schwartz BS.

Int J Hyg Environ Health. 2018 Mar;221(2):323-333. doi: 10.1016/j.ijheh.2017.12.005. Epub 2017 Dec 15.

49.

Antimicrobial Resistance of Sterile Site Infections in Sub-Saharan Africa: A Systematic Review.

Workneh M, Katz MJ, Lamorde M, Cosgrove SE, Manabe YC.

Open Forum Infect Dis. 2017 Oct 6;4(4):ofx209. doi: 10.1093/ofid/ofx209. eCollection 2017 Fall.

50.

Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort.

Chotiprasitsakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Conley AT, Tolomeo P, Wise J, Tamma PD; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2018 Jan 6;66(2):172-177. doi: 10.1093/cid/cix767.

Supplemental Content

Loading ...
Support Center